CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC) by Health Canada for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria ...

In the first quarter of 2026, Alnylam generated $125.7 million in net product revenues from its rare disease portfolio (Givlaari and Oxlumo), reflecting a 15% year-over-year increase. Expanding global ...

A creature that stalks the night with a thirst for human blood has starred in nightmares for centuries. People once buried their loved ones with stakes in their chests to keep them from rising out of ...

Brendan McGuire, MD, discusses hallmark clinical features of the rare disease, acute hepatic porphyria, diagnostic delays, unnecessary operations, and more. Dr Sherman: Hi everybody, I’m Dr Gregg ...

When Britain’s King George III died in 1820, he was blind, deaf and apparently mad. His physicians, limited in their medical knowledge and hindered by protocol in examining their royal patient (they ...

Acute hepatic porphyria (AHP) is a group of rare genetic disorders that affect the liver’s ability to produce heme, a vital component of blood, and can manifest with a variety of symptoms often ...

An acute hepatic porphyria (AHP) episode is a medical emergency with severe symptoms like intense pain and seizures. Having a pre-arranged emergency plan is crucial for prompt treatment and to avoid ...

It never seems to fail. Right around Halloween, questions start popping up about a rare and serious disease linked to vampire lore and the madness of King George. Porphyrias are a group of hereditary ...

Acute hepatic porphyria (AHP) is one of a group of disorders that are triggered by a buildup of pigments called porphyrins in your liver and elsewhere. The disorder can cause nerve problems and other ...

Acute Intermittent Porphyria Market Outlook 2025-2035: The acute intermittent porphyria market size reached a value of USD 1.76 Million in 2024. Looking forward, the market is expected to reach USD ...